ENDPOINTS

Firings sweep across FDA, hittings leadership and whole...

Mass firings and forced resignations swept through the FDA on Tuesday, as part o...

Firings sweep across FDA, gutting leadership and whole ...

Mass firings and forced resignations swept through the FDA on Tuesday, as part o...

Talkspace makes AI therapy podcasts for patients

Talkspace is using AI to make mini podcast episodes from patients’ therapy sessi...

RNA editing startup AIRNA raises $155M for liver and lu...

When the transatlantic startup AIRNA launched in 2023, it was already years behi...

Big ambitions at Merck and AstraZeneca — along with a f...

Step back from the multitude of details that go into every big pharma pipeline, ...

Lilly claims Phase 2 win for siRNA approach to mixed dy...

Eli Lilly’s RNA candidate has reduced levels of a protein linked with cardiovasc...

Sanofi continues its bet on R&D by poaching GSK’s head ...

Sanofi is boosting its research and development team by hiring GSK’s former head...

J&J’s third talc bankruptcy bid is stopped by Texas fed...

A federal judge on Monday dismissed a Johnson & Johnson subsidiary’s third attem...

Federal judge nixes FDA's lab-developed test rule

The FDA overstepped its authority when it issued a rule last May to bring labora...

FDA changes may not be over after Marks exit, with more...

A top official pushed out over vaccines. Senior staff heading for the exit. Thou...

DC court sides with HHS in Vertex's fertility program f...

Vertex lost a legal battle against the federal government on Monday over its pro...

Heart gene therapy company Tenaya to lay off 30% to 40%...

Heart gene therapy maker Tenaya Therapeutics is laying off 30% to 40% of its sta...

Vaxcyte's Phase 2 pneumococcal vaccine data disappoint ...

Vaxcyte’s stock price {$PCVX} dropped by 50% on Monday after the company reporte...

FDA reschedules opioid-focused advisory meeting

A meeting of outside experts to discuss the FDA’s post-marketing requirements fo...

Corcept shares soar after Phase 3 win in ovarian cancer

Corcept Therapeutics’ oral glucocorticoid receptor antagonist has improved survi...

Merck’s PAH drug slashed risk of serious events in halt...

New data unveiled Monday showed that Merck’s Winrevair can significantly cut the...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.